Blood-based test identifies presence of amyloid plaques in symptomatic adults and is intended to be used in conjunction with a clinical assessment ...

Manu Subhashchandrabose built an AI validation framework for enterprise systems, using predictive testing, self-healing automation, drift monitoring, and continuous validation to make probabilistic AI ...

Jarwan talks about the "conversion layer" between infrastructure and value, why AI sovereignty is a 'team sport', and what it takes to move AI from the screen to the shop floor ...

The US Food and Drug Administration has given the go-ahead for a new test to confirm or rule out the presence of amyloidosis ...

Almost a week later, on August 10, 2026, the FDA cleared Quantum BioPharma's investigational new drug (IND) application for Lucid-MS (Lucid-21-302), a first-in-class compound targeting demyelination, ...

A one-year AI moratorium offers real protection for students at school—but it won’t prepare them for the AI they encounter ...

Cancer Horoscope Today: The day has a social and productive tone, with support coming through ordinary interactions rather ...

Presentations will highlight the clinical utility and long-term commercial opportunity of GENFIT’s proprietary NIS platform, ...